Cardinal Health, Inc. (NYSE:CAH) will participate in the Leerink's 2025 Global Healthcare Conference Call on March 12, 2025, at 8:40 AM ET. The company representatives include Aaron Alt, the Chief Financial Officer, and Matt Sims from Investor Relations. Mike Cherny from Leerink will also be part of the conference call.
Prairie Operating, Intuit, and Cardinal Health are showing significant growth in their earnings.
At Zacks, we concentrate on the reliable Zacks Rank system, which highlights earnings estimates and changes in those estimates to identify excellent stocks. However, we also keep an eye on the most recent trends in value, growth, and momentum to support our top selections.
At Zacks, we concentrate on the reliable Zacks Rank system, which highlights earnings estimates and changes in those estimates to identify excellent stocks. At the same time, we keep an eye on the most recent trends in value, growth, and momentum to support our top selections.
On Thursday, Cardinal Health CAH announced that its financial results for the second quarter were better than anticipated.
Cardinal Health, Inc. (NYSE:CAH) will hold its Q2 2025 Earnings Conference Call on January 30, 2025, at 8:30 AM ET. The call will feature company representatives including Matt Sims, Jason Hollar, and Aaron Alt, along with participants from various financial institutions. The event will be coordinated by George, who will guide the discussion.
The Zacks Style Scores help investors quickly identify highly-rated stocks that match their investment preferences. Here are some reasons to make the most of this tool.
Cardinal Health (CAH) reported quarterly earnings of $1.93 per share, which is higher than the Zacks Consensus Estimate of $1.75 per share. This is an increase compared to earnings of $1.82 per share from the same period last year.
On Thursday, Cardinal Health, a drug distributor, increased its profit expectations for fiscal 2025. This change is due to high demand for expensive specialty medicines and branded drugs, which boosted sales in its pharmaceuticals division.
Cardinal Health reported a revenue of $55.3 billion for the second quarter of fiscal year 2025, which is a 4% decrease compared to the same period last year. However, if we exclude the effects of a major customer contract ending, revenue actually rose by 16%. The company also announced that it has completed its acquisition of a 73% stake in GI Alliance.